Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)
Others
Ratios

BioNexus Gene Lab (BGLC) Interest & Investment Income (2024 - 2025)

Historic Interest & Investment Income for BioNexus Gene Lab (BGLC) over the last 2 years, with Q3 2025 value amounting to $20778.0.

  • BioNexus Gene Lab's Interest & Investment Income fell 4067.16% to $20778.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $108011.0, marking a year-over-year change of. This contributed to the annual value of $147641.0 for FY2024, which is 11498.51% up from last year.
  • According to the latest figures from Q3 2025, BioNexus Gene Lab's Interest & Investment Income is $20778.0, which was down 4067.16% from $29768.0 recorded in Q2 2025.
  • In the past 5 years, BioNexus Gene Lab's Interest & Investment Income registered a high of $49739.0 during Q2 2024, and its lowest value of $20778.0 during Q3 2025.